30 Sep 2021
CBMG Holdings Completes $120 Million in Series A Funding, Accelerating Development of CAR-T Therapy Pipelines and R&D for Innovative Solid Tumor Therapies
Author: admintech | Filed under: Press ReleaseHONG KONG, Sept. 30, 2021 /PRNewswire/ — CBMG Holdings (or the “Company”), a Cayman Island biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer and degenerative diseases, today announced the closing of a $120 million Series A investment,…